rivastigmine
Generic: rivastigmine
Labeler: northstar rx llc.Drug Facts
Product Profile
Brand Name
rivastigmine
Generic Name
rivastigmine
Labeler
northstar rx llc.
Dosage Form
PATCH, EXTENDED RELEASE
Routes
Active Ingredients
rivastigmine 13.3 mg/24h
Manufacturer
Identifiers & Regulatory
Product NDC
16714-117
Product ID
16714-117_eb0de734-0cf3-4e83-b14e-feebe76390e0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206318
Listing Expiration
2026-12-31
Marketing Start
2019-10-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
16714117
Hyphenated Format
16714-117
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
rivastigmine (source: ndc)
Generic Name
rivastigmine (source: ndc)
Application Number
ANDA206318 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 13.3 mg/24h
Packaging
- 30 POUCH in 1 CARTON (16714-117-02) / 24 h in 1 POUCH (16714-117-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TRANSDERMAL"], "spl_id": "eb0de734-0cf3-4e83-b14e-feebe76390e0", "openfda": {"nui": ["N0000175723", "N0000000177"], "upc": ["0316714115023", "0316714116020", "0316714117027"], "unii": ["PKI06M3IW0"], "rxcui": ["725021", "725023", "1308569"], "spl_set_id": ["8b809739-8381-4cc1-ab4a-5b17ab902a3d"], "pharm_class_epc": ["Cholinesterase Inhibitor [EPC]"], "pharm_class_moa": ["Cholinesterase Inhibitors [MoA]"], "manufacturer_name": ["Northstar Rx LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (16714-117-02) / 24 h in 1 POUCH (16714-117-01)", "package_ndc": "16714-117-02", "marketing_start_date": "20191001"}], "brand_name": "Rivastigmine", "product_id": "16714-117_eb0de734-0cf3-4e83-b14e-feebe76390e0", "dosage_form": "PATCH, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "16714-117", "generic_name": "Rivastigmine", "labeler_name": "Northstar Rx LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine", "active_ingredients": [{"name": "RIVASTIGMINE", "strength": "13.3 mg/24h"}], "application_number": "ANDA206318", "marketing_category": "ANDA", "marketing_start_date": "20191001", "listing_expiration_date": "20261231"}